Citations

Showing 10 of 108135 citations.

Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population
Rattan, Puru , Penrice, Daniel D. , Ahn, Joseph , Ferrer, Alejandro, Patnaik, Mrinal M. , Shah, Vijay H. , Kamath, Patrick S. , Mangaonkar, Abhishek A. , Simonetto, Douglas A. , Ahn, Joseph C , Penrice, Daniel , Simonetto, Douglas A , Ferrer, Alejandro

Mayo Clinic

Hepatology Communications | August 28, 2021 | Volume: 6 | Issue: 2 | Pages: 399-410

10.1002/hep4.1803 | PMID 34558851 Get It

Physiologic aging leads to attrition of telomeres and replicative senescence. An acceleration of this process has been hypothesized in the progression of chronic liver disease. We sought to examine the association of telomere length (TL) with liver disease and its impact on mortality risk. A cohort of 7,072 adults with leukocyte TL measurements from the National Health and Nutrition Examination Survey 1999‐2002 with mortality follow‐up through 2015 was analyzed. Liver disease was defined by aminotransferase levels and classified into etiology‐based and advanced fibrosis categories. Multivariable‐adjusted linear regression models estimated effect sizes, with 95% confidence intervals (CIs), of the presence of liver disease on TL. Cox regression models evaluated associations between TL and all‐cause mortality risk using adjusted hazard ratios (HRs). The cohort was representative of the US population with mean age 46.1 years and mean TL 5.79 kilobase pairs. No overall association between TL and liver disease was found; however, there was a significant negative association of TL and advanced liver fibrosis in individuals aged 65 and above. The liver disease cohort (HR 1.22, 95% CI 0.99‐1.51) and those with metabolic syndrome (HR 1.26, 95% CI 0.96‐1.67) had increased mortality risk with shorter TL. The relationship between TL and all‐cause mortality was stronger in women (HR 1.51, 95% CI 1.02‐2.23) and in non‐Hispanic Whites (HR 1.37, 95% CI 1.02‐1.84). Conclusion: Shortened leukocyte TL is independently associated with advanced liver disease at older ages, and with a higher risk of all‐cause mortality in those with liver disease. These associations reaffirm the need to better understand the role of telomeres in the progression of liver disease.
Vitamin D Status and Severe COVID-19 Disease Outcomes in Hospitalized Patients
Pecina, Jennifer L. , Merry, Stephen , Park, John G. , Thacher, Tom D. , Merry, Stephen P , Pecina, Jennifer , Thacher, Thomas D

Mayo Clinic

Journal of Primary Care & Community Health | August 28, 2021 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/21501327211041206 | PMID 34452582 Get It

Background: Vitamin D deficiency may increase the risk of severe COVID-19 disease. Objectives: To determine if 25-hydroxyvitamin D [25(OH)D] levels in patients hospitalized for COVID-19 were associated with the clinical outcomes of days on oxygen, duration of hospitalization, ICU admission, need for assisted ventilation, or mortality. Methods: We conducted a retrospective study of 92 patients admitted to the hospital with SARS-CoV-2 infection between April 16, 2020 and October 17, 2020. Multivariable regression was performed to assess the independent relationship of 25(OH)D values on outcomes, adjusting for significant covariates and the hospitalization day the level was tested. Results: About 15 patients (16.3%) had 25(OH)D levels <20 ng/mL. Only 1 patient (3.4%) who had documented vitamin D supplementation prior to admission had 25(OH)D <20 ng/mL. Serum 25(OH)D concentrations were not significantly associated with any of our primary outcomes of days on oxygen, duration of hospitalization, intensive care unit (ICU) admission, need for mechanical ventilation, or mortality in any of the adjusted multivariable models. Adjusting for the hospital day of 25(OH)D sampling did not alter the relationship of 25(OH)D with any outcomes. Conclusion: Vitamin D status was not related to any of the primary outcomes reflecting severity of COVID-19 in hospitalized patients. However, our sample size may have lacked sufficient power to demonstrate a small effect of vitamin D status on these outcomes.
High‐fidelity simulation and nurse clinical competence—An integrative review
O’Rourke, Laura A. , Morrison, Megan , Grimsley, Amy , Cotter, Valerie T.

Mayo Clinic

Journal of Clinical Nursing | August 28, 2021 | Volume: 32 | Issue: 9-10 | Pages: 1549-1555

10.1111/jocn.16028 | PMID 34453385 Get It

Abstract Aim The aim of this review was to synthesise current knowledge of high‐fidelity simulation practices and its impact on nurse clinical competence in the acute care setting. Background There is no consensus or standardisation surrounding best practices for the delivery of high‐fidelity simulation in the acute care setting. This is an understudied area. Design An integrative review using Johns Hopkins Nursing Evidence‐Based Practice Model. Methods Medical subject heading terms ‘Clinical Competence’, AND ‘High Fidelity Simulation Training’, AND ‘Clinical Deterioration’ were systematically searched in PubMed, CINAHL and Embase databases for peer‐reviewed literature published through September 2020. The current study was evaluated using PRISMA checklist. Results Seven studies met the inclusion criteria. Three main concepts were identified: modes of delivery, approach to learner participation and outcome measurement. Conclusions This review substantiated the use of high‐fidelity simulation to improve acute care nurses’ early identification and management of clinical deterioration. Global variations in course design and implementation highlight the need for future approaches to be standardised at the regional level (i.e., country‐centric approach) where differing scopes of practice and sociocultural complexities are best contextualised. Relevance to clinical practice These findings add to the growing body of evidence of simulation science. Important considerations in course planning and design for nursing clinical educators were uncovered. This is especially relevant given the current COVID‐19 pandemic and urgent need to train redeployed nurses safely and effectively from other units and specialties to acute care.
Endoscopic submucosal dissection vs. endoscopic mucosal resection for early Barrett's neoplasia in the West: a retrospective study
Pérez, Lady Katherine Mejía , Draganov, Peter V. , Jawaid, Salmaan , Chak, Amitabh , Dumot, John A. , Alaber, Omar , Jang, Sunguk , Mehta, Neal , Chua, Tiffany , Gabr, Moamen , Kudaravalli, Praneeth , Aihara, Hiroyuki , Ngamruengphong, Saowanee , Khoshknab, Milad Pourmousavi, Bhatt, Amit , Mejia Perez, Lady Katherine , Alaber, Omar , Fukami, Norio , Maluf-Filho, Fauze , Bhatt, Amit , Yang, Dennis J. , Vargo, John Joseph , Fukami, Norio

Mayo Clinic

Endoscopy | August 27, 2021 | Volume: 54 | Issue: 05 | Pages: 439-446

10.1055/a-1541-7659 | PMID 34450667 Get It

Abstract Background The difference in clinical outcomes after endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) for early Barrett's esophagus (BE) neoplasia remains unclear. We compared the recurrence/residual tissue rates, resection outcomes, and adverse events after ESD and EMR for early BE neoplasia. Methods We included patients who underwent EMR or ESD for BE-associated high grade dysplasia (HGD) or T1a esophageal adenocarcinoma (EAC) at eight academic hospitals. We compared demographic, procedural, and histologic characteristics, and follow-up data. A time-to-event analysis was performed to evaluate recurrence/residual disease and a Kaplan–Meier curve was used to compare the groups. Results 243 patients (150 EMR; 93 ESD) were included. EMR had lower en bloc (43 % vs. 89 %; P < 0.001) and R0 (56 % vs. 73 %; P = 0.01) rates than ESD. There was no difference in the rates of perforation (0.7 % vs. 0; P > 0.99), early bleeding (0.7 % vs. 1 %; P > 0.99), delayed bleeding (3.3 % vs. 2.1 %; P = 0.71), and stricture (10 % vs. 16 %; P = 0.16) between EMR and ESD. Patients with non-curative resections who underwent further therapy were excluded from the recurrence analysis. Recurrent/residual disease was 31.4 % [44/140] for EMR and 3.5 % [3/85] for ESD during a median (interquartile range) follow-up of 15.5 (6.75–30) and 8 (2–18) months, respectively. Recurrence-/residual disease-free survival was significantly higher in the ESD group. More patients required additional endoscopic resection procedures to treat recurrent/residual disease after EMR (EMR 24.2 % vs. ESD 3.5 %; P < 0.001). Conclusions ESD is safe and results in more definitive treatment of early BE neoplasia, with significantly lower recurrence/residual disease rates and less need for repeat endoscopic treatments than with EMR.
Detecting cardiomyopathies in pregnancy and the postpartum period with an electrocardiogram-based deep learning model
Adedinsewo, Demilade , Johnson, Patrick W. , Douglass, Erika J. , Attia, Itzhak Zachi, Phillips, Sabrina D. , Yamani, Mohamad H. , Connolly, Heidi M. , Rose, Carl H., Sharpe, Emily E. , Blauwet, Lori A., Friedman, Paul A. , Carter, Rickey E. , Adedinsewo, Demilade A , Goswami, Rohan M, Yamani, Mohamad H , Sharpe, Emily E , Lopez-Jimenez, Francisco , Carter, Rickey E , Johnson, Patrick W , Attia, Itzhak Zachi, Goswami, Rohan , López-Jiménez, Francisco , Noseworthy, Peter A.

Mayo Clinic

European Heart Journal - Digital Health | August 27, 2021 | Volume: 2 | Issue: 4 | Pages: 586-596

10.1093/ehjdh/ztab078 | PMID 34993486 Get It

Abstract Aims Cardiovascular disease is a major threat to maternal health, with cardiomyopathy being among the most common acquired cardiovascular diseases during pregnancy and the postpartum period. The aim of our study was to evaluate the effectiveness of an electrocardiogram (ECG)-based deep learning model in identifying cardiomyopathy during pregnancy and the postpartum period. Methods and results We used an ECG-based deep learning model to detect cardiomyopathy in a cohort of women who were pregnant or in the postpartum period seen at Mayo Clinic. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity. We compared the diagnostic probabilities of the deep learning model with natriuretic peptides and a multivariable model consisting of demographic and clinical parameters. The study cohort included 1807 women; 7%, 10%, and 13% had left ventricular ejection fraction (LVEF) of 35% or less, &lt;45%, and &lt;50%, respectively. The ECG-based deep learning model identified cardiomyopathy with AUCs of 0.92 (LVEF ≤ 35%), 0.89 (LVEF &lt; 45%), and 0.87 (LVEF &lt; 50%). For LVEF of 35% or less, AUC was higher in Black (0.95) and Hispanic (0.98) women compared to White (0.91). Natriuretic peptides and the multivariable model had AUCs of 0.85 to 0.86 and 0.72, respectively. Conclusions An ECG-based deep learning model effectively identifies cardiomyopathy during pregnancy and the postpartum period and outperforms natriuretic peptides and traditional clinical parameters with the potential to become a powerful initial screening tool for cardiomyopathy in the obstetric care setting.
Acute Effect of Height-Adjustable Workstations on Blood Glucose Levels in Women with Impaired Fasting Glucose Levels While Working: A Pilot Study
Bonikowske, Amanda R. , Carpenter, Katie C , Stovitz, Steven D. , Pereira, Mark A. , Lewis, Beth A. , Pereira, Mark A , Bandyopadhyay, Dipankar

Mayo Clinic

Translational Journal of the American College of Sports Medicine | August 27, 2021 | Volume: 6 | Issue: 4 | Pages: No page available

10.1249/tjx.0000000000000171 | PMID 35668746 Get It

ABSTRACT Objective This study aimed to examine the effect on continuously monitored blood glucose (BG) among participants with impaired fasting glucose (IFG) who used a height-adjustable desk while working. Methods The study was a repeated-measures pilot study in overweight or obese women who had IFG (BG >100 mg·dL −1 ) and a sedentary job. BG was monitored with continuous glucose monitoring devices during two 1-wk periods at work: 1 wk in the seated position and 1 wk using alternate bouts of sitting and standing (by adjusting their desks) throughout the workday. Results Ten women completed the study. Sedentary time significantly predicted BG independently of diet and overall physical activity ( P = 0.02). Dietary carbohydrates, protein, and fat were significant predictors of BG ( P < 0.001). Conclusions Sedentary time is a strong predictor of increased BG in women with IFG and a sedentary job.
Abstract 10: MANP Activation of the Cyclic GMP/PDE2/CYP11B2 Pathway Inhibits Aldosterone In Vitro and In Vivo
Chen, Yang , Lee, Hon-chi, Burnett, John C. , Iyer, Seethalakshmi , Nikolaev, Viacheslav O. , Naro, Fabio , Pellegrini, Manuela

Mayo Clinic

Hypertension | August 27, 2021 | Volume: 78 | Issue: Suppl_1 | Pages: No page available

10.1161/hyp.78.suppl_1.10 Get It

Aldosterone is a critical driver for cardiovascular disease (CVD). We recently discovered that MANP, a novel atrial natriuretic peptide (ANP) analog, possessed more potent aldosterone inhibitory action than ANP. MANP is currently entering clinical trials for hypertension and thus understanding its aldosterone suppressing mechanism is important. The mechanism of aldosterone inhibition by natriuretic peptides (NPs) remains to be clearly defined. Conflicting results were reported on the roles of particulate guanylyl cyclase A receptor (pGC-A) and NP clearance receptor (NPRC) in aldosterone inhibition. Furthermore, the functions of protein kinase G (PKG) and phosphodiesterases (PDE) on aldosterone regulation are not clear. Herein, we investigated the molecular mechanism of aldosterone regulation in the human adrenocortical cell line H295R and in mice. We firstly showed that pGC-A mediates aldosterone inhibition. In contrast, with NPRC agonist and antagonist, we showed that NPRC did not inhibit aldosterone. Next, we confirmed that MANP inhibits aldosterone via PDE2, not PKG, with specific agonists, antagonists, siRNA silencing, and fluorescence resonance energy transfer (FRET) experiments. Specifically, MANP suppressed ANGII mediated activation of aldosterone (fold change) MANP+ANGII 3.2±0.1* vs. ANGII 3.8±0.1 (*p<0.05) with IBMX, a PDEs inhibitor and the PDE2 antagonist Bay 60-7550 reversed MANP-mediated aldosterone suppression (IBMX+MANP+ANGII 3.9±0.2 and Bay+MANP+ANGII 4.1±0.1). With PKG agonists and inhibitors, aldosterone levels were not changed. In PDE2 activity FRET studies, aldosterone control was 3.7±0.4 and with MANP 0.9±0.2* supporting PDE2 activation by MANP. Further, the inhibitory effect of PDE2 is mediated by a reduction of intracellular Ca2+ concentration (~22%). We then showed that MANP directly reduced aldosterone synthase CYP11B2 expression in vitro. Lastly, in PDE2 knockout mice (embryonic lethal), embryonic adrenal CYP11B2 expression is markedly increased (wild type: 1±0.2, KO: 2.8±0.5*). Our findings innovatively elucidate the pGC-A/cGMP/PDE2 pathway in aldosterone inhibition by MANP in vitro and in vivo. Additionally, our data also support the development of MANP as a novel ANP analog drug for CVD.
Prevalence and clinical outcomes of pleural effusion in COVID‐19 patients: A systematic review and meta‐analysis
Rathore, Sawai Singh , Hussain, Nabeel , Manju, Ade Harrison, Wen, Qingqing , Tousif, Sohaib , Capriles, Camilo Andrés Avendaño , Woodbine, Maria Jose Hernandez , Rojas, Gianpier Alonzo , Vatsavayi, Priyanka , Tera, Chenna Reddy, Ali, Muhammad , Saleemi, Shayan, Patel, Deep, Avendaño-Capriles, Camilo Andrés , Hernandez-Woodbine, Maria Jose , Singh, Romil

Mayo Clinic

Journal of Medical Virology | August 27, 2021 | Volume: 94 | Issue: 1 | Pages: 229-239

10.1002/jmv.27301 | PMID 34449896 Get It

AbstractObservational studies indicate that pleural effusion has an association with risk and the clinical prognosis of COVID‐19 disease; however, the available literature on this area is inconsistent. The objective of this systematic review and meta‐analysis is to evaluate the correlation between COVID‐19 disease and pleural effusion. A rigorous literature search was conducted using multiple databases. All eligible observational studies were included from around the globe. The pooled prevalence and associated 95% confidence interval (CI) were calculated using the random effect model. Mantel–Haenszel odds ratios were produced to report overall effect size using random effect models for severity and mortality outcomes. Funnel plots, Egger regression tests, and Begg–Mazumdar's rank correlation test were used to appraise publication bias. Data from 23 studies including 6234 COVID‐19 patients was obtained. The overall prevalence of pleural effusion in COVID‐19 patients was 9.55% (95% CI,I2 = 92%). Our findings also indicated that the presence of pleural effusions associated with increased risk of severity of disease(OR = 5.08, 95% CI 3.14–8.22,I2 = 77.4%) and mortality due to illness(OR = 4.53, 95% CI 2.16–9.49,I2 = 66%) compared with patients without pleural effusion. Sensitivity analyses illustrated a similar effect size while decreasing the heterogeneity. No significant publication bias was evident in the meta‐analysis. The presence of pleural effusion can assist as a prognostic factor to evaluate the risk of worse outcomes in COVID‐19 patients hence, it is recommended that hospitalized COVID‐19 patients with pleural effusion should be managed on an early basis.
Tranexamic Acid Was Not Associated with Increased Complications in High-Risk Patients with Hip Fracture Undergoing Arthroplasty
Spaulding, Aaron , Duncan, Christopher M. , Wilke, Benjamin K. , Pagnano, Mark W. , Abdel, Matthew P. , Porter, Steven B , Spaulding, Aaron , Duncan, Christopher M , Wilke, B K , Pagnano, Mark W , Abdel, Matthew P , Porter, Steven B.

Mayo Clinic

Journal of Bone and Joint Surgery | August 27, 2021 | Volume: 103 | Issue: 20 | Pages: 1880-1889

10.2106/jbjs.21.00172 | PMID 34449443 Get It

Background: Tranexamic acid (TXA) is considered safe and efficacious for elective total joint arthroplasty. However, evidence of TXA’s safety in high-risk patients with hip fracture requiring nonelective arthroplasty has been lacking. This study aimed to assess whether TXA administration to high-risk patients with a hip fracture requiring arthroplasty increased the risk of thrombotic complications or mortality. Methods: All patients who underwent hip hemiarthroplasty (HHA) or total hip arthroplasty (THA) for displaced femoral neck fractures between 2011 and 2019 at 4 sites within 1 hospital system were retrospectively identified. Patients were grouped by risk (high-risk or low-risk) and TXA treatment (with or without TXA). Propensity scores were used for risk adjustment in comparisons between surgery with and without TXA for only the high-risk group (n = 1,066) and the entire population (n = 2,166). Differences in the occurrence of postoperative mortality, deep venous thrombosis, pulmonary embolism, myocardial infarction, and stroke within 90 days of hip arthroplasty were evaluated. Results: TXA administration was not associated with an increased risk of thrombotic complications or mortality within 90 days in either high-risk or all-patient groups. Specifically, among 1,066 matched high-risk patients who did not or did receive TXA, there were no significant differences in mortality (14.82% and 10.00%; p = 0.295), deep venous thrombosis (3.56% and 3.04%; p = 0.440), pulmonary embolism (2.44% and 1.96%; p = 0.374), myocardial infarction (3.38% and 2.14%; p = 0.704), or stroke (4.32% and 5.71%; p = 0.225). Conclusions: In our review of 1,066 propensity-matched high-risk patients undergoing hip arthroplasty for displaced femoral neck fractures, we found that TXA administration (compared with no TXA administration) was not associated with an increased risk of mortality, deep venous thrombosis, pulmonary embolism, myocardial infarction, or stroke. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
An irradiated marrow niche reveals a small non-collagenous protein mediator of homing, dermatopontin
Kramer, Ashley C. , Astuti, Yuliana, Elfstrum, Alexis K. , Lehrke, Michael Jonathan , Tolar, Jakub , Blazar, Bruce R. , Blake, Amanda L., Taisto, Mandy, Furcich, Justin W. , Nolan, Erin E. , Webber, Beau R. , Geisness, Athena , Lehrke, Michael J , Durose, Wilaiwan W , Webber, Beau R , Blazar, Bruce R , Tolar, Jakub , Wood, David K. , Lund, Troy C.

Mayo Clinic

Blood Advances | August 27, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1182/bloodadvances.2021004475 | PMID 34448828 Get It

Hematopoietic cell homing after hematopoietic cell transplant (HCT) is governed by several pathways involving marrow niche cells that are evoked after pre-HCT conditioning. To understand the factors that play a role in homing, we performed expression analysis on the zebrafish marrow niche cells following conditioning. We determined that the non-collagenous protein extracellular matrix related protein dermatopontin (Dpt) was upregulated seven-fold in response to irradiation. Studies in mice revealed DPT induction both with radiation and lipopolysaccharide exposure. Interestingly, we found that co-incubation of zebrafish or murine hematopoietic cells with rDPT impedes hematopoietic stem and progenitor cell homing by 50% and 86%, respectively. Similarly, this translated into a 24% reduction in long term engraftment (versus control, p = 0.01). We found DPT to interact with VLA-4 and block hematopoietic - endothelial cell adhesion and transendothelial migration. Finally, a DPT knockout mouse displayed a 60% increase in homing of hematopoietic cells versus wildtype (p = 0.03) with slight improvement in long-term LSK-SLAM engraftment (2-fold, p = 0.04). These data show that the extracellular matrix (ECM)-related protein DPT increases with radiation and transiently impedes the transendothelial migration of hematopoietic cells to the marrow.